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ABSTRACT 
In recent years drug bioavailability has become a subject of matter not only in drug development, additionally within the early stages of drug 
discovery. Bioavailability is the major and important pharmacokinetic property of drug. This property of drug is used to describe the fraction of  
an administered dose of unchanged drug which can reaches to the systemic circulation. When a drug is administered intravenously, its 
bioavailability is 100%.and if the drug is administered through other routes like oral, its bioavailability decreases because of the incomplete 
absorption or first pass metabolism. So there is a need in the enhancement of the bioavailability of sustained release dosage form. This is a 
consequence of the finding that the majority of candidate drugs that were unsuccessful in clinical trials did so because of problems with 
absorption, distribution, metabolism, excretion (ADME) and toxicology. Efforts are being created within the Pharmaceutical industry to 
improve success rates by taking into account the ADME and toxicology aspects in drug discovery. The efficacy of a drug fur ther depends on the 
ability of the dosage to deliver the active drug to the site of action and at a rate and amount which is sufficient to show the desired 
pharmacological response. This property is also known as bioavaibility or biologic availability. 
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Introduction 
Bioavaibility is one of the most important factors. This factor 
is used to achieve the optimal concentration of drug in 
systemic circulation. When a drug has a poor bioavaibility 
then it shows poor solubility, slow dissolution rate, poor 
stability of drug and extensive first pass metabolism.1 Over 
the past thirty years, because the expense and 
complication concerned in   new entities have hyperbolic 
with concomitant recognition of the medical aid benefits 
of controlled drug delivery, bigger attention has been 
centered on development of sustained or controlled drug 
delivery system. 1Goal of designing sustained release 
delivery systems is to increase the effectiveness of drug by 
localization at the site of the action, to reduce frequency of 
dosing or for providing uniform drug delivery.2 The ideal 
drug delivery systems has require two things which would 
be first it would be a single dose, the duration of treatment 
whether it is for days or week, as with infection, or for the 
life time of the patient, as in hypertension or diabetes. It 
should deliver the active entity directly to the site of the 
action by minimizing side effects.5 Bioavailability 
refers to the relative amount of drug from the administered 
dosage  form  which  enters  into  the  systemic  circulation  
and  the  rate  at which the drug appears in systemic 
circulation.3 
Oral sustained release products give us an advantage over 
conventional dosage forms which can optimize 
biopharmaceutics and pharmacokinetic property of drug 
when it is incorporated in Nanoparticulate system. 
Pharmacokinetic property includes bioavaibility of drug.4It 
includes any drug delivery system achieves release of drug 
over an extended period of time, which not timedependent. 
Hydrophilic polymer matrix is widely used for formulation 
of Sustained dosage form. The role of ideal drug delivery 
system is to provide proper amount of drug at regular time 
interval and attarget site of action to maintain therapeutic 
effect of drug in blood plasma4 
Bioavailability will be typically documented by a systemic 
exposure profile obtained by measuring drug concentration 
in the systemic circulation over time. The systemic exposure 
profile determined during clinical trials in the early drug 
development can serve as a benchmark for subsequent 
bioequivalence studies. Bioequivalence studies should be 
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conducted for the comparison of two medicinal products 
containing the same active substance. Two products 
marketed by totally different licensees, containing same 
active ingredients, must be shown to be therapeutically 
equivalent to one another in order to be considered 
interchangeable. Several test methods are available to assess 
equivalence5 
From time to time varied authors have proposed 
different types of drug release mechanisms from 
matrices. It has been planned that drug release from 
matrices usually implies water penetration in the matrix, 
hydration, swelling, diffusion of the dissolved drug 
(polymer hydro fusion), and/or the erosion of the 
gelatinous layer. Several Kinetics models are relating to 
the drug release from matrices. They are selected from 
the most important mathematical models, are described 
over here. However, it is worth mention that the release 
mechanism of a drug would depend upon the dosage 
from selected, pH, nature of the drug and, which type of 
polymer used.6 
Rational of sustained drug delivery: 
The basic principle for sustained drug delivery is to improve 
the pharmacokinetics and pharmacodynamics of 
pharmacological active moieties by using Nanoparticulate 
system.Formulation of sustained drug delivery minimizes 
dosing frequency and sustained release provides availability 
of a drug at action site throughout the treatment to improve 
clinical efficiency of a drug molecule.7 
Advantages of sustained release dosage form: 7 
 SR dosage form improves potency in treatment 
optimized medical care and a lot of uniform blood 
concentration. 
 It reduces in fluctuation of drug level and because 
of that more uniform pharmacological response, 
cure of control of condition more promptly, less 
reduction in drug activity with chronic use. 
 Method by which sustained unharness is achieved, 
will improve the bioavailability of some medication. 
 Encapsulation for chemical compound systems 
required is appropriate for unharness sustained. 
 It can be protected by encapsulation in polymer 
systems suitable for sustained release. 
 It also improves patient compliance, less frequent 
dosing, reduced night-time dosing and reduced 
patient care time. 
 The importance of patient compliance in flourishing 
drug medical care is well recognized. 
 It has been found that there is an inverse 
relationship between the quantity of dosages as per 
the day and therefore the compliance rate. 
 Although the initial unit cost of sustained release 
products is usually greater than that of 
conventional dosage forms because of the special 
nature of these products, the average cost of 
treatment over an extended period of time is less. 
 Due to economy it may also result a decrease in 
nursing time and hospitalization time. 
 Improvement in bioavailability of some drugs because 
of spatial control. 
 
 Disadvantages of sustained release dosage form: 7 
 It gives delay onset of drug action. 
 It has a chance of dose dumping within the case of a 
poor formulation strategy. 
 III.It has increased potential of first pass metabolism 
 Possibility of less accurate dose adjustment in some 
cases. 
 Cost per unit dose is higher when compared with 
conventional doses. 
Challenges in sustained drug delivery: 
Biocompatibility Cost of formulation, preparation and 
processing fate of polymer additives, Fate of controlled 
release system if not biodegradable. e.g., plasticizers, 
stabilizers, antioxidants.4Although the oral drug delivery is 
effective for drug with epithelial permeabilityand high 
solubility, systematic oral administration of poorly water 
soluble drug is a challengeand high solubility. Presently, 
most of the new chemical entities are lipophilic and have 
poor solubility On the basis of biopharmaceutical 
classification system, a number of new therapeutic entities 
are characterized under BCS class II (high permeability and 
low solubility) or BCS class IV(low permeability and low 
solubility).8The oral bioavailability of some drugs is also 
affected by their poor gastrointestinal permeability. To 
reach to the certain level oftherapeutic action, these drugs 
have to be given at a high dose. Moreover, chemical barriers 
presented by the gastrointestinal tract also affect oral 
administration.8Bioavailability is one of the essential 
tools in sustainedbecause it should be thought about 
when calculating dosages for non-intravenous routes of 
administration. It is known as absolute or relative 
bioavailability.9 
Bioavailability: 
Absolute bioavailability: Compares the bioavailability of 
the same drug following intravenous administration with 
the bioavailability of the active drug in systemic circulation 
following non-intravenous administration. The comparison 
must be dose normalized; the amount absorbed is corrected 
by dividing on the corresponding dose administered.10this is 
the dose corrected AUC intravenousdivided by area under 
curve no intravenous. Therefore, a drug given by the 
intravenous route will have an absolute bioavailability of 
one while drugs given by other routes usually have man 
absolute bioavailability of less than one. If we compare the 
bioavailability of two ingredients, it is called comparative 
bioavailability.11 
Relative bioavailability: The term relative bioavailability 
denotes to a comparison of two or more dosage forms in 
terms of their relative rate and extent of absorption. If an 
intravenous injection is employed as the reference dose, 
then can determine the complete bioavailability of the test 
dosage form. Two dosage forms which don’t differ in their 
extent and rate of absorption are termed bioequivalent. 
Bioequivalence determinations is made bypharmaceutical 
alternatives which can be defined as drug products that 
contain the identical therapeutic moiety or its precursor, but 
it is not necessarily in the same amount or as the same 
salt.Every single product meets the identical compound and 
alternative applicable standard of identity, strength, quality, 
purity as well as efficiency, content uniformity, and 
dissolution rates.12  
Factors influencing bioavailability: 
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The factors affecting the release and bioavailability of 
contaminants present in sediments through thenatural and 
anthropogenic disturbance, events are analyzed and our 
current state of understanding of those processes studied. 
Available data are focused on the distribution of 
contaminants within undisturbed sediment, these affinities 
to the various solid-phase fractions and the interaction of 
contaminants between sediment and pore water. Sediment 
disturbance can lead to change in chemical properties of 
sediment which stimulates mobilization of contaminants. 
Research shows that changes in redox potential and pH can 
increase speed for desorption, partitioning, bacterial 
degradation and the oxidation,when these processes are 
sediment- and compound-specific. With the affection of the 
affinity of contaminants to sediments and disturbance 
events will have a big impact on the bioavailability. Few 
research have examined this development and it is clear 
from that there are gaps in our understanding in a number 
of key areas where the assessing the release of contaminants 
from sediments is done. The fate of contaminants in 
undisturbed sediments and those which are not subjected to 
major disturbances, the kinetic processes which regulate 
metal release through the changes in redox potential, from 
sediments through the repeat procedure of suspension, the 
bioavailability of organic and the processes affecting 
contaminant release.12 
Techniques for improving bioavailability: 
1. Enhancement of solubility and dissolution rate 
2. Modification of partition coefficient 
3. Avoidance of hepatic first pass metabolism 
4. Avoidance of degradation in gastrointestinal tract 
5. Novel Drug Delivery system. 
Enhancement of solubility and dissolution rate: 
Physical Modification: 
Particle size reduction: 
Particle size reduction increases the effective surface area 
which results in enhancement of solubility and dissolution 
velocity of the drug. Micronization and nanonization these 
techniques are used to improve dissolution rates of drugs 
which further improve the oral bioavailability of same. 
Micronization of drugs is done by milling techniques using 
jet mill, colloid mills etc. 10 
Eg. Farinha Aet. Alhas found important increase which is in 
the oral bioavailability of micronized Megestrol acetate from 
in vivo study. To overcome these limitations of 
micronizationalternative approach used is nanonization. 
Nanonizationresults in formation of nanosuspension. 
Nanosuspension is a micron dispersion of pure particles of 
drug stabilized by surfactants. It increases dissolution rate 
due to larger surface area exposed to gastrointestinal fluid.10 
E.g. Jia L. et al has found that this formulation enhances rat 
oral bioavailability of the poorly soluble thiadiazole 
derivative. 
pH adjustment: 
It is well documented that the influence of the changes in pH 
within the gastrointestinal tract upon the bioavailability of 
pharmaceuticals. The absorption of drug is largely 
dependent upon diffusion, which varies with pH of the 
individual regions within the gastrointestinal tract, the pKa 
of the drug and permeability, which are not only moderated 
by the surface area of the region in which it is released, but 
also the regional pH effects upon drug ionization. By 
applying a pH change, poorly water soluble drugs with parts 
of the molecule that can be protonated (base) or 
deprotonated (acid) may potentially be dissolved in water. 
While the importance of critical parameters like salt 
selection and pH adjustment has been stressed on pre-
formulation, the use of pH altering excipients within drug 
delivery systems is also of significant utility. pH adjustment 
can in principle be used for both oral and parenteral 
administration.13 
Chemical modification: 
Change in pH of system: 
When organic solutes which are ionizable then changing the 
pH of system is simplest and most effective which will 
increases the aqueous solubility, with the help of proper 
conditions the solubility of an ionizable drug increases by 
adjusting the pH of the solution,which further improve the 
oral bioavaibility.14  
Salt formation: 
Salt formation is very common and effective method for 
increase in the solubility and dissolution rates of acidic 
drugs and basic drugs. It is main parameters to changes in 
solubility and permeability of the molecule, which can 
further improve bioavailability. The use of salt forms is a 
technique for enhancement of dissolution rates. Alkaloidal 
base is very less soluble in water but when the pH of 
medium is reduced by adding the acid the solubility of the 
base is increases as the pH continues to be reduced. The 
solubility of very less soluble acid which increases as when 
the pH is increased by adding alkali. This is the reason of salt 
formation.14 
Formulation Based Approaches: 
a) Co-crystallization:  
Co-crystals are alternative option for salt formation for 
neutral compounds or for those which have weakly 
ionizable groups to modify the chemical and physical 
properties of an active pharmaceutical ingredient without 
making covalent bonds. It is also referred as molecular 
complexes. This will help to improve the bioavaibility.14 
b) Co-solvency: 
Weak electrolytes have poor water solubility which is 
improved by changing the polarity of the solvent which is 
done generally by the adding water miscible solvent which 
the has good solubility. It is prominent that the addition of 
an organic co solvent can change the solubility of drugs. This 
process is known as co solvency and the solvents are known 
as co solvents. This improves the oral bioavaibility of that 
drug. 14 
c) Solid dispersion: 
Solid dispersion is the system made up of one or more active 
ingredients which are dispersed in inert carrier in a solid 
state. SD are classified as follows: first generation as 
crystalline carriers such as urea, second generation 
amorphous carriers which are generally polymers and third 
generation carriers with surface activity properties. 
Generallyit contains surfactant or a mixture of surfactants. 
They are prepared by the fusion method, solvent method 
and fusion solvent-method. Eutectic mixtures are also form 
of solid dispersions which are also prepared by fusion 
method with the help of specific solvents on the basis of a 
formulation strategy to improve the physical properties of 
the active ingredient for the enhanced dissolution rate and 
solubility.15 
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1. Modification of partition coefficient: 
a. Ester formation: 
This denotes to improvement in oral bioavailability of poorly 
water-soluble drugs by chemical derivatization to a water-
soluble prodrug. It utilizes esterification of a hydroxyl, amine 
or carboxyl group of a drug with a moiety (progroup) 
designed to introduce an ionizable function or reduce 
intermolecular interactions responsible for low solubility. 
The use of spacer groups to introduce derivatizable 
functions and/or to position ionizable progroups for 
unhindered hydrolysis is also described.14 
2. Avoidance of first pass metabolism: 
a. Prodrug Approach: 
This approach is used to reduce the presystemic metabolism 
and also for chemical decomposition. The basic and 
important principle linked with Prodrug is to cover the 
functional group. Designation of prodrug is used for 
improving the oral and nasal bioavaibility. This is one of the 
best approaches for protein and peptide molecules. Ideal 
prodrug foe bioavaibility enhancement of these would 
exhibit enhanced membrane permeability with increased 
stability. After crossing enzymatic membrane barrier the 
Prodrug undergoes enzymatic transformation to reduce the 
parent molecules.16 
b. Co-administration with another drug: 
If a drug has a high first-pass metabolism then one can 
expect an increase in its plasma concentration. When it is co-
administered with another drug then it inhibits its 
metabolism. When administered alone lopinavir has 
insufficient bioavailability (25%); but when like HIV 
protease inhibitors, its blood levels are increased by low 
doses of ritonavir, a potent inhibitor of cytochrome P450.14 
3. Avoidance of degradation in gastrointestinal tract 
a. Avoidance of degradation in stomach – Enteric 
coating 
An enteric coatingis a barrier for oral medication which 
resists destructive action of the gastric fluid and then 
disintegrates in the intestinal tract by releasing the drug in 
the intestine. Reasons for enteric-coating a drug product is 
as follows: 
 Preventing destruction of the drug by gastricenzymes 
or by the acidity of the gastric fluid 
 Preventing nausea and vomiting caused by the drug’s 
irritation of the gastric mucosa 
 Delivering a drug that is primarily absorbed in the 
intestines to that site at the highest possible 
concentration 
Enteric coating worksthrough presenting a surface which is 
stable at the highly acidic pH which is found in the stomach 
but breaks down rapidly at a less acidic pH (basic pH). For 
example they will not dissolve in the acidic juices of the 
stomach with pH ~3 but will dissolve in the higher pH which 
is above pH 5.5. Materials which are used for enteric 
coatings include fatty acids like stearic acid, hydrogenated 
castor oil, waxes like carnauba wax, cellulose acetate 
phthalate and shellac. The enteric materials are used to coat 
tablets, capsules andgranules.  
b. Avoidance of degradation in intestine – 
Many drugs are stable in the acidic environment of stomach 
but cannot resist the pH and enzymatic conditions of the 
intestine. An increase in the residence time of such drugs in 
stomach leads to the absorption of significant amount in 
stomach before it reaches the intestine.14 
Novel Drug Delivery system 
Nano suspensions, Nanoemulsions, Selfmicroemulsifying 
and self-nanoemulsifyingdrug delivery system, Solid lipid 
nanoparticles, polymeric nanoparticles,Vesicular delivery 
systems such as liposomes, niosomes etc.10Drugs who has 
poor solubility possess the tough scenarioin formulation by 
applying typical approaches as they present issues like slow 
onset of action, poor oral bioavailability, lack of dose 
proportional, failure to achieve steady state plasma 
concentration, and side effects. The conventional dosage 
forms thus may result in over- or undermedication and poor 
patient compliance. These challenges are also overcome by 
making them as novel drug delivery systems which canoffers 
edgessuch as reduction in dose frequency, lowering of dose 
size, specific targeting, increasedporosity, and improvement 
in oral bioavailability. Nanotechnology is a very good and 
promising strategy in which the development of drug 
delivery systems for those potent drugs whose clinical 
development was unsuccessfulbecause to their poor 
solubility, low permeability, inadequate bioavailability, and 
other poor biopharmaceutical properties.17  
    
Novel drug delivery systems are one of the IMP methods in 
which they alters to beat the issues associated with the drug 
bioavailability. It is the rate and extent to which a drug 
becomes available to the target, once its administration is 
done. Most of the newest drugs used have poor 
bioavailability and are required to be administered at higher 
doses because only a small fraction of the administered dose 
is absorbed within the circulation and ready to reach the 
target site.18 
1. Nano suspensions: 
Nano suspensions are biphasic colloidal dispersions of drug 
particles in which they are stabilized by using surfactants. 
Nano suspensionshave particles dispersed in an aqueous 
vehicle with the size of particle less than 1 μm. Nano 
suspensions can overcome the problems related to the 
delivery of poorly water soluble drugs due to their Nano size 
particle range.19 Nano suspensions are part of 
nanotechnology which consists of poorly water soluble drug 
without any matrix material suspended in dispersion. One of 
the major problems which is associated with poorly soluble 
drugs is the very low bioavailability of drug. The problem is 
more complex for drugs such asItraconazole, Simvastatin, 
and Carbamazepine which are weakly soluble in aqueous 
and no aqueous media, belonging to as classified by 
biopharmaceutical classification system.Formulation as 
Nano suspension is an attractive and promising alternative 
to solve these problems. This approach is most suitable for 
the compounds with high log P value, melting point and 
dose.19 
Various methods likelyophilization also known as 
freezedrying;spray drying, melt granulation, and extrusion-
spheronization are used for the preparation of 
nanosuspension. These have been applied for converting 
Nano suspensions to pellets or tablet-like dosage forms.19 
Method for preparation of Nano suspension 
1. Lyophilization: 
Lyophilization is a process into which water is frozen and 
then it is removed from the sample initially by sublimation 
and then by desorption. this is the process of drying in which 
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water is sublimed from the product after it is frozen. For 
prolonged storage a drying process applicable to 
manufacture of certain chemicals, pharmaceuticals and 
biological that are thermolabile or otherwise unstable in 
aqueous solutions and it is stable in the dry state. The term 
lyophilization describes a process to produce a product that 
loves the dry state. Lyophilization is performed at 
temperature and pressure conditions below the triple point 
of water, to enable sublimation of Ice.20 
2. Spray Drying: 
Spray drying includes the spraying of liquid feed formulation 
such as solutions, suspensions, emulsions into a hot drying 
medium (air, nitrogen).  The droplets  formed  by  the  
atomisation  process  are  dried  through  solvent 
evaporation to form particles which are collected as a dry 
powder.The  drying  of  the  spray  continues  until  the  
desired moisture content in the dried particles is achieved, 
and the product  is  recovered  from  the  air.  It  is  a  unique  
drying process  since  it  involves  both  particle  formation  
and drying.  Process  parameters  such  as  inlet  and  outlet 
temperature  of  the  drying  medium  and  the  atomization 
pressure influence the physico-chemical properties of  the 
produced powders. The  characteristics  of  the  spray dried 
powder can be  controlled, and the powder properties  can 
be  maintained  constant  throughout  the  continuous 
operation.  With  the  different  designs  of  spray  dryers 
available, it is possible to select a dryer layout to produce 
either  fine  or  coarse  particle  powders,  agglomerates  or 
granulates.21 
3. Melt Granulation: 
This is the technique in which powder agglomeration is 
obtained through the addition of a lipid as binder that melts 
or softens at relatively low temperatures. In melt 
granulation technique it offers several advantages over the 
conventional wet granulation since the liquid addition and 
the subsequent drying phase are omitted. The main 
parameters which control the granulation process are listed 
such as impeller speed, mixing time, binder particle size, and 
the viscosity of the binder. A wide range of solid lipids and 
semisolid lipids can be applied as meltable binders.22  
4. Melt Extrusion/Extrusion Spheronization: 
Melt Extrusion has been used in the plastic, rubber, and food 
manufacturing industry to produce items ranging from pipes 
to sheets and bags. With the advent of high throughput 
screening, currently more than half of all plastic products 
including bags, sheets, and pipes are manufactured my HME 
and therefore various polymers have been used to melt and 
form different shapes for a variety of industrial and domestic 
applications. The technology (HME) has proven to be a 
robust method of producing numerous drug delivery 
systems and therefore it has been found to be useful in the 
pharmaceutical industry as well. Extrusion is the process of 
pumping raw materials at elevated controlled temperature 
and pressure through a heated barrel into a product of 
uniform shape and density. Breitenbach first introduced the 
development ofmelt extrusion process in pharmaceutical 
manufacturing operations10however, Follonier and his 
coworkers first examined the hot-melt technology to 
manufacture sustained release polymer-based pellets of 
various freely soluble drugs. 
Advantages of use of Nano suspensions for enhancement 
of bioavaibility: 
 Nano suspensions are cost-effective and technically 
simpler alternative.  
 Nano suspension shows good reproducibility in case of 
large-scale production.  
 It also increases the dissolution rate and saturation 
solubility.  
 It gives efficient release of hydrophobic drugs 23 
2. Nanoemulsions: 
Nanoemulsions are dispersions of shear-induced ruptured 
Nano scale droplets. It can be defined as oil-in-water 
emulsions with mean droplet diameters ranging from 50 to 
1000nm. It is very likely that Nanoemulsions played 
commercially important role; since they can typically 
formulate with the help of less surfactant than is required 
for nanostructured lyotropic microemulsion phases. 
Nanoemulsions are kinetically stable, even for several years. 
The term sub–micron emulsion, mini-emulsion and ultra-
fine emulsion are used as synonyms. It has to be considered 
that these novel Nanoemulsions again are fluid systems 
where the production is not easy to handle. Different 
techniques for the production of Nanoemulsions are High 
pressure homogenization in which disruptive forces are 
responsible for conversion of coarse emulsion into 
Nanoemulsions and Low energy emulsification methods, in 
which condensation forces are utilized for this purpose. A 
narrow size distribution can be obtained using Micro 
fluidization technique, where emulsions are forced through 
micro channels in the central chamber of the micro fluidizer 
using high pressure pump. A heterogeneous distribution of 
droplet size is achieved using Ultra sonication technique 
which uses ultrasound energy to disrupt macroscopic 
droplets. Lipophilic drug entrapped lipid nanoemulsions 
improved bioavailability of drugs by increasing drug 
absorption through the gastrointestinal tract.24 
Nanoemulsions were shaped both by high energy 
emulsification methods or low energy emulsification 
methods. High energy emulsification methods engage high 
shear mixing, high-pressure homogenization or 
ultrasonication, while low energy emulsification methods 
used the advantage of the physicochemical properties of the 
system which exploits phase transitions to produce 
nanoemulsions. Nanoemulsion prepared with oil, surfactant 
and Cosurfactant are non-toxic, non-irritant and approved 
for humans.3 
Advantages of use of nanoemulsions for enhancement of 
bioavaibility: 
 Nanoemulsions eliminate variability in absorption by 
increasing the rate of absorption.  
 Nanoemulsions are effective transport system because 
these have much higher surface area and free energy 
and also do not possess problems of inherent 
creaming, flocculation, coalescence and sedimentation 
which are commonly associated with macro emulsions.  
 These show rapid and efficient permeability of the 
drug moiety thus there is significant increase in 
bioavailability.  
 Since theseare formulated with surfactants which are 
approved for human consumption, they can be taken 
by enteric route.17 
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3. Self-emulsifying, Self-micro emulsifying (SMEDDS) 
and Self-nano emulsifying (SNEDDS) drug delivery 
system: 
Self-Emulsifying: 
The self-emulsifying drug delivery systems offers 
advantages in addressing the challenges of drug solubility 
and absorptionof drug; the next challenge stays the delivery 
of the drug in an acceptable dosage form. The oral dosage 
forms are the preferred drug administration route, and lipid 
formulations offer flexibility for oral dosage because they 
can be formulated as solutions, semisolid, and solid forms. 
Conventional self-emulsifying drug delivery systems are 
prepared in a liquid form which then can produce some 
disadvantages such as low stability, irreversible 
drugs/excipients precipitation, large volume of dose, 
difficulty in handling and portability, and few choices of 
dosage forms12 so because of that  the need for development 
of solid SEDDS 
Solidification Technique for converting Liquid SEDDS to 
Solid-SEDDS 
Solid SEDDSs are being developedfrom liquid/semisolid 
SEDDS mainly by adsorptionon solid carriers, spray drying, 
lyophilization; melt extrusion, and nanoparticals technology. 
Such powders/nanoparticles, which are then, referred to SE 
nanoparticles/solid dispersions, which are processed into 
other solid SE dosage forms.24 
SMEDDS gives a great potential by improving the oral 
bioavailability of therapeutic agents. Some of the nano-
emulsions such as surfactants which can inhibit the 
Cytochrome P450 metabolizing enzymesWherethe few 
lipidic components like glyceryl monooleate, long-chain 
triglycerides have been shown to promote the lymphatic 
absorption of the therapeutic agents which prevent the first 
pass metabolism of the drugs. The SMEDDS have been found 
to be useful in improving the oral bioavailability of drugs in 
which it undergoes degree of firstpass metabolism. The 
developed SMEDDS formulations improves the oral 
bioavailability and the relative oral bioavailability of 
SMEDDS compared with available tablets was 413%.25  
SNEDDS are oil-in-water Nanoemulsions which are in the 
form of anhydrous isotropic mixture of surfactant, oil, and 
drugs. When these introduced into aqueous phase with 
gentle agitation get transformed into nanoemulsions. The 
digestive motility of gastrointestinal tract gives agitation for 
formation of nanoemulsions. The SNEDDS givesaids 
associated with nanoemulsions such asincrease in oral 
bioavailability and increase inporosity of drug, improved 
chemical/enzymatic stability, and ease of fabrication.25 
Advantages of use of Self-nanoemulsifying for 
enhancement of bioavaibility: 17 
 Self-nanoemulsifying DDS gives protection for 
sensitive drug substance  
 Ithas a selective targeting for drugs toward specific 
absorption window in GIT. 
 It gives controlled drug delivery profiles. 
 It used inenhancement in oral bioavailability which 
enables the reduction in dose. 
 It reduced variability like food effects  
 It has more regular temporal profiles of drug 
absorption  
 
4. Solid lipid nanoparticle: 
SLNs are aqueous dispersions of solid lipids which has a size 
ranges between 50 to 1000 nm. A clear advantage and bold 
advantage of solid lipidnanoparticle is the fact in which lipid 
matrix is made from physiologically tolerated lipid 
components, which decreases the potential for acute and 
chronic toxicity. SLNs involvethe advantages for polymeric 
nanoparticles and liposomes. They are melt-emulsified 
nanoparticles which are depends on type of lipids used at 
room temperature. SLNs were prepared by many 
techniques. This technique mainly involves high pressure 
homogenization and microemulsiontechnique. To 
manufacture SLNs hot high pressure homogenization above 
melting point of lipid and subsequent crystallization is 
recommended but for thermo labile drugs cold high 
pressure homogenization exists. Other production methods 
for SLN are the precipitation. These mainly differ from 
ultrasound, normally in particle size distribution. One of the 
major advantages of SLNs over other systems is the 
reduction in acute and chronic toxicity due to the presence 
of physiologically tolerated lipid components. SLN is a 
promising strategy in bioavailability enhancement. SLNs 
give benefits like biocompatibility, nontoxicity and stability 
against coalescence. Solid lipid nanoparticles can be also be 
applied for delivery of hydrophilic and for hydrophobic 
drug20 
Lipids have been used as an alternative carrier for polymeric 
nanoparticles, particularly for lipophilic pharmaceuticals 
and lipid nanoparticles are known as solid lipid 
nanoparticles (SLNs). SLNs introduced in 1991 represent an 
alternative and suitable system to traditional colloidal 
carriers such as emulsions, liposomes and polymeric micro 
and nanoparticles. The system consists of spherical solid 
lipid particles in the nanometer ranges, which are dispersed 
in water or in aqueous surfactant solution. SLN are made of 
solid hydrophobic core having a monolayer of phospholipids 
coating. The hydrophobic chains of phospholipids 
incorporated in the fat matrix and have the potential to carry 
lipophilic or hydrophilic drugs or diagnostics25 
Advantages of use of solid lipid nanoparticle for 
enhancement of bioavaibility: 
 SLN have adhesive properties which make them 
adhere to gut wall and then releases the drug exactly 
where it should be absorbed.  
 These improve the bioavailability of drugs with the 
help ofdecreasing first pass metabolism. 
 SLNconsists of high biocompatibility and controlled 
release 
 They do not have any problems with multiple route of 
administration like oral, intravenous, pulmonary and 
transdermal administration.17 
4.1 Nanoparticles: 
The word nanoparticlesderived from nanostructures 
particulate with variable shape but with at least one 
dimension in Nano scale, which should be lower than 100 
nanometers.These drug delivery technologies offers many 
advantages like increased bioavailability, extended drug 
half-life and reduced off-target toxicities. The new 
generation of therapeutic nanoparticle is a multifunctional 
combination of an active drug compound with selective 
targeted moieties. In many cases imaging agents which 
permit localization by standard x-ray, magnetic resonance 
or positron emission tomography technologies. Mesoporous 
silica nanoparticles areused in controlled delivery of 
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hydrophilic or hydrophobic active agents. Later advances in 
the MSNs surface properties like surface functionalization 
and PEGylation rendered them as a promising drug delivery 
vehicle for cancer treatment.Polymer systems offers 
immense flexibility in customization and optimization of 
nanocarrier to efficiently deliver new therapeutics and 
provide an integral step in aiding their progression to 
clinical practice.13 
The term nanoparticles name of combination forNano 
spheres and Nano capsules. Nano spheresare matrix system 
in which drug is uniformly dispersed and nanocapsules are 
the system in which the drug is surrounded by a unique 
polymeric membrane.This systemic review gives the 
Classification, method ofpreparation, Characterization, 
application and health prospective. 
Classification of nanoparticles 
There are various approaches for classification of 
Nanomaterials. They are classified based on one, two and 
three dimensions  
a. One dimension nanoparticles 
This system includes thin film or manufactured surfaces 
which has been used for electronics, chemistry and 
engineering. Production of thin films sizes1 to 100nm is now 
common place in the field of solar cells or catalysis. These 
thin films are then used in different technological 
applicationswhich gives information about storage systems, 
chemical and biological sensors, fiber-optic and magneto-
optic system and optical device.22 
b. Two dimension nanoparticles 
These are also known as Carbon nanotubes. They are 
hexagonal network of carbon atoms, 1 nm in diameter and 
100 nm in length, as a layer of graphite rolled up into 
cylinder. CNs are of two types, single walled carbon 
nanotubes and multi-walled carbon nanotubes.The small 
dimensions of carbon nanotubes, combined with their 
remarkable physical, mechanical and electrical properties 
which make them unique material. They displays metallic 
conductive properties, depending on how the carbon leaf is 
wound on itself. The current density which can reach one 
billion amperes per square meter making it a 
superconductor. Mechanical strength of carbon nanotubes is 
sixty times more than the best steels. Nanotubes have a 
more capacity for molecular absorption and offering a three 
dimensional configuration. Nanotubes are chemically very 
stable.22 
c. Three dimension nanoparticles 
These are also known as Fullerenes. They are spherical 
cages consisting from 28 to 100 carbons which contain C60. 
They are a hollow ball made upof interconnected carbon 
pentagons and hexagons which resembles as asoccer ball. 
Fullerenes are materials of class displaying unique physical 
properties. They can be exposed to extreme pressure 
andreformed in their original shape when the pressure is 
released. These molecules don’t combine with each other, 
giving them major potential for application as lubricants. 
They have interesting electrical properties, it has been 
suggested to use them in the electronic field, ranging from 
data storage to production of solar cells.22. 
Vesicular delivery system 
Liposomes 
Liposomes are vesicles made up of a hydrophobic lipid 
bilayer film of numerous sorts of natural cells. The 
medication of liposomes is inactive dissemination because of 
the layer and uptake of the vesicles with the help of other 
lipid bilayer structure. A novel class of liposomes 
nanoparticles has been used with labeled antibodies on their 
surfaces which can further gofor about homing ligands, 
guarantee awesome capability of acknowledging multi-
reason shrewd vehicles for pin-point conveyance of a show 
of payloads at a Nano scale. The adjusted liposomes are a 
compelling approach to target heart, liver, kidney, lungs and 
bone. With the advancement of innovation, liposomes 
intervened medication conveyance will assume a more vital 
part in clinical environment later on. The principle 
inconvenience of liposome is that it is difficult to cross most 
customary pellicle hindrances because of their forced size.23 
Liposomes are one of the most extensively investigated 
colloidal carriers which are used to improve the therapeutics 
of potent drugs, can be further used to control retention of 
entrapped drugs in the presence of biological fluids by target 
cells. With respect to oral administration liposomes 
formulation are targeted to reduce toxicity and improve 
bioavailability. For acid labile drugs, like Cefpodoxime 
entrapment by liposomes which provide a temporary 
protection for the drug from the hostile acidic environment 
of the stomach. Also they increases the intestinal 
permeability which is induced by the lipid components of 
liposomes.19 
An outer hydrophobic environment is established with the 
linkage of a lipophilic moiety of the player and non-polar 
part lipophilic can associate depending upon their geometry 
and size8. Hydrophilic drugs or molecules interact with the 
inner aqueous phase of the vesicles. This bypass 
characteristic composition and construction of liposomes 
offer a dynamic and adaptable technology for enhancing 
drug solubility. These can be classified depending upon the 
size, the number of players and the existence of inner 
vesicles as multilamellar large vesicles, oligolamellar 
vesicles, unilamellar vesicles, small unilamellar vesicles, 
medium sized unilamellar vesicles, large unilamellar 
vesicles, giant unilamellar vesicles and multi vesicular 
vesicles.23 
Advantages of use of liposomes for enhancement of 
bioavaibility: 
 Liposomes encapsulate hydrophilic and lipophilic 
drugs which are then protect them from degradation. 
 PEGylated liposomes have advantages such as increase 
bioavailability and the targeted delivery to the organs 
which needed most of them.  
 Liposomes regulates the membrane permeability and 
so they do not allow the leakage of solute.17 
Niosomes: 
Niosomes are nonionic surfactant vesicles which are well 
recognized for drug delivery vehicles. They can also carry 
hydrophilic drugs by encapsulation and are quite 
stable.Preliminary studies specify that niosomes increases 
the absorption of some drugs from the gastrointestinal tract 
following oral ingestion.  Improved oral bioavailability 
owing to the lipophilic nature of the niosomes formulation 
and the effect of the nonionic surface-active agent on the 
permeability of the gastrointestinal membrane. Improved 
portioning of the lipophilic system to the mucosa, a direct 
effect of the surface active agent on the barrier function of 
the mucosa, and prolonged localization of the drug-loaded 
niosomes at the site of absorption may be possible reasons 
for the improved bioavailability23 
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Advantages of use of niosomes for enhancement of 
bioavaibility: 
 Niosomes are successfully using for oral administration 
of peptide or protein drugs like insulin to reduce the use 
injection as the mode of administration.  
 Niosomes increases stability of entrapped drug as they 
are osmotically active and stable.  
 These provide enhancement of skin permeation and 
improvement of oral bioavailability of poorly soluble 
drug.  
 Structure of the noisome is designed by such a way that 
thevesicles can entrap hydrophilic and lipophilic as well 
as amphiphilic drug moieties. 
Bilosomes: 
Bilosomes are the novel, innovative drug delivery carriers 
which is produced by incorporating deoxycholic acid into 
the membrane of niosomes. Incorporation of bile in the 
formulation which could then stabilize the membrane 
against the effects of bile acids in the gastrointestinal tract 
where conventional vesicles such as liposomes and 
niosomes which can cause dissolution and undergo 
enzymatic degradation. These bile salts then stabilized 
vesicles which are known as blossoms. These show various 
advantages likebiocompatibility as they are produced from 
naturally occurring lipids. Bile salts along with lipid content 
increase the bioavailability of enclosed bioactive substance 
and act as penetration enhancers. These have been found to 
increase in the bioavailability of drugs as they can absorb 
through the small intestine into the circulation19 
Advantages of use of Bilosomes for enhancement of 
bioavaibility: 
 Bilosomes increases the bioavailability of bioactive 
substance and also act as penetration enhancers  
 In this bile salts used as a penetration enhancers in the 
formulation which could stabilize the membrane 
against the effects of bile acids in GI tract17 
Transferosomes: 
These are ultra-flexiblelipid supramolecular aggregates 
which easily penetrate skin intact. Conventional drug 
carriers aren’t suitable for transdermal delivery because 
their poor skin permeability, breaking of vesicles, leakage of 
drug, aggregation and fusion of vesicles. Transferosomes are 
the promising NDDS which are capable of transdermal 
delivery of low molecular weight drugs as well as high 
molecular weight drugs. These have at least one inner 
aqueous compartment which is then surrounded by a lipid 
bilayer and edge activatorslike sodium chelate, sodium 
deoxycholate, span and Tween 80.  They are attached to a 
vesicular membrane.8 
Transfersomes were developed in order to take the 
advantage of phospholipids vesicles as transdermal drug 
carrier. These self-optimized aggregates, with the ultra-
flexible membrane, are able to deliver the drug reproducibly 
either into or through the skin, depending on the choice of 
administration or application, with high efficiency. These 
vesicular Transfersomes are several orders of magnitudes 
more elastic than the standard liposomes and thus well 
suited for the skin penetration. Transfersomes overcome the 
skin penetration difficulty by squeezing themselves along 
the intracellular sealing lipid of the stratum corneum. There 
is provision for this, because of the high vesicle 
deformability, which permits the entry due to the 
mechanical stress of surrounding, in a self-adapting manner. 
Flexibility of Transfersomes membrane is achieved by 
mixing suitable surface-active components in the proper 
ratios26 
Advantages of use of Transferosomes for enhancement 
of bioavaibility: 
 These are suitable for transdermal drug delivery which 
have ultra-deformable vesicles which can squeeze 
itself through a pore  many times smaller than its size 
owing17 
Dendrimers: 
Dendrimers are innovative polymeric carrier attracting 
attention due to their advantages such as three-dimensional 
structure, nanometer size, narrow polydispersity index, and 
controlled molecular structure whichcan help for 
accompanied with multiple functional groups. The word 
Dendrimers derives from a Greek word Dendra which has a 
meaning of reminiscent of a tree. Dendrimers has a size 
ranges between 1 to 100 nm with distinct domains: first is a 
core which is at the center containing atom with at least 2 
identical chemical functions, second one is the branches 
which are the units repeated in geometric progression that 
leads to radially concentric layers known as generations and 
the third terminal functional groups are at the surface which 
determines the properties of Dendrimers. Dendrimers were 
applied as a versatile drug delivery system for delivery of 
drugs, gene, proteins and peptides. For different 
pharmaceutical purposes, dendrimers have also been 
formed as conjugates by linking to different carriers such as 
liposomes, CNTs, and nanoparticles. Few applications of 
dendrimers include both Solubilization and gene therapy. 
The conjugation and encapsulation of drug with dendrimers 
have provided a platform for oral delivery of hydrophobic.17 
Structure of dendrimers has a well-defined size, shape and 
defined molecular weight and also Dendrimers are hyper-
branched, globular, monodisperse, three dimensional 
nanoscales synthetic Polymers. Molecular chemistry and 
polymer chemistry both exhibit well-defined characteristics 
features of Dendrites27 
Advantages of use of dendrimersfor enhancement of 
bioavaibility: 
 Dendrimers are highly promising platforms because of 
the modularity andtailoring their physicochemical and 
biological properties which can further helps to 
achieve precise targeted outcomes. 
Conclusion 
Drugs poor solubility, its poor bioavailability have major 
difficulty in administration of drug, to overcome this 
nanotechnology have great potential. For overcoming 
difficulties in the administration of drugs having poor 
solubility’s, poor bioavailability, Nanoparticulate drug 
carriers provide great potential. The important 
characteristics of the drugs such as solubility, bioavailability 
and Pharmacokinetic, Pharmacodynamic properties and can 
be improved by nano particulate carrier systems. The 
nanosystems has some important advantages as 
biocompatibility, colloidal size, drug targeting, lowered dose 
size, reduced toxicity, and patient compliance. Thus, 
nanotechnology offers opportunity for formulation scientists 
to extend research and development. It can be concluded 
that nanocarriers offer a promising vehicle for the 
improvement of bioavailability of poorly soluble drug 
candidates. 
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